HK Stock Market Move | Zhejiang Sanhua Intelligent Controls (02050) surged more than 5% after the performance report. The net profit attributable to the parent company in the first quarter was 928 million yuan, continuing to promote the development of the data center field.
Sanhua Intelligent Control (02050) rose by more than 5% after its performance announcement, reaching 5.08% as of the time of publication, with a price of 33.5 Hong Kong dollars and a trading volume of 316 million Hong Kong dollars.
Zhejiang Sanhua Intelligent Controls (02050) rose more than 5% after the performance report, up 5.08% as of the time of writing, at HK$33.5, with a trading volume of HK$316 million.
On the news front, on April 29, Zhejiang Sanhua Intelligent Controls released its first quarter report for 2026. The company achieved operating income of 7.774 billion yuan, an increase of 1.36% year-on-year. The net profit attributable to shareholders of the listed company was 928 million yuan, an increase of 2.68% year-on-year, with basic earnings per share of 0.22 yuan.
Guosen previously pointed out that Zhejiang Sanhua Intelligent Controls continues to promote development in the data center field, focusing on the global data center and computing power industry, continuously tracking industry trends and demand changes. New areas such as server liquid cooling, Siasun Robot & Automation are expected to contribute to incremental growth.
Related Articles

HK Stock Market Move | TS Lines (02510) fell by nearly 4%, with first-quarter revenue decreasing by 11.48% year-on-year to 288 million US dollars.

HK Stock Market Move | TRIGIANT (01300) surged more than 8% in early trading, with first quarter revenue up more than 50% year-on-year and gross profit increasing by nearly 93%.

New stock news | Deit Medicine's Hong Kong Stock IPO prospectus has become invalid.
HK Stock Market Move | TS Lines (02510) fell by nearly 4%, with first-quarter revenue decreasing by 11.48% year-on-year to 288 million US dollars.

HK Stock Market Move | TRIGIANT (01300) surged more than 8% in early trading, with first quarter revenue up more than 50% year-on-year and gross profit increasing by nearly 93%.

New stock news | Deit Medicine's Hong Kong Stock IPO prospectus has become invalid.

RECOMMEND





